Skip to content
Disclosery

EXANE DERIVATIVES: IWM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on IWM, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 425 IWM shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 425 shares
    Change vs previous 13F 0 shares

    0.04% of the 13F portfolio, value $71,962.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 425 shares
    Change vs previous 13F -1,211 shares

    0.02% of the 13F portfolio, value $87,233.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,636 shares
    Change vs previous 13F +420 shares

    0.09% of the 13F portfolio, value $363,910.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,216 shares
    Change vs previous 13F +67 shares

    0.07% of the 13F portfolio, value $265,987.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,149 shares
    Change vs previous 13F +40 shares

    0.06% of the 13F portfolio, value $255,415.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,109 shares
    Change vs previous 13F -490 shares

    0.07% of the 13F portfolio, value $245,008.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,599 shares
    Change vs previous 13F -1,350 shares

    0.1% of the 13F portfolio, value $313,480.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,949 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $441,712.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).